Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.084,58
0,12%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Dor Biopharma (DOR) Dor Biopharma (DOR) Notizie

DOR

Dor (DOR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:DOR
DataOraFonteTitoloSimboloCompagnia
07/04/200615:19Business WireDOR BioPharma Announces Advances in Mucosal Vaccines for Botulinum Toxin; Antigens are Made Using Dowpharma's Pfenex ExpressionAMEX:DORDor Biopharma
06/04/200621:28Business WireDOR BioPharma Announces Private Equity Financing of $3.65 Million with Institutional InvestorsAMEX:DORDor Biopharma
30/03/200616:00Business WireDOR BioPharma Reports Year End 2005 Financial Results and Accomplishments; DOR Provides Guidance on Regulatory Filings on orBecAMEX:DORDor Biopharma
08/02/200615:25Business WireDOR BioPharma Provides Financial Guidance and Update on European Regulatory Plans for orBec(R)AMEX:DORDor Biopharma
30/01/200623:48Business WireDOR BioPharma Announces Positive Phase I Results of RiVax(TM), its Vaccine Against Ricin Toxin; Vaccine is Immunogenic and WellAMEX:DORDor Biopharma
25/01/200616:31Business WireDOR BioPharma Achieves Manufacturing Milestone in Development of RiVax(TM); DOR and Its Collaborators Achieve 2nd Milestone AheaAMEX:DORDor Biopharma
20/01/200614:10Business WireDOR BioPharma Reports Positive New Survival Findings from Previously Completed Phase II and III Clinical Trials of orBec(R); ResAMEX:DORDor Biopharma
19/01/200615:26Business WireDOR BioPharma Secures $6 Million Equity Commitment from Fusion CapitalAMEX:DORDor Biopharma
15/11/200515:04Business WireDOR BioPharma Plans FDA NDA and European MAA Filing Strategy for orBecAMEX:DORDor Biopharma
14/11/200522:26Business WireDOR BioPharma Inc. Reports Third Quarter 2005 Financial Results and Reviews Recent Achievements; Conference Call Scheduled for NAMEX:DORDor Biopharma
07/11/200513:00Business WireDOR BioPharma to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare ConferenceAMEX:DORDor Biopharma
02/11/200512:00Business WireDOR BioPharma Executes Letter of Intent for Acquisition of Gastrotech Pharma; Acquisition Bolsters Biotherapeutics PipelineAMEX:DORDor Biopharma
01/11/200522:34Business WireDOR BioPharma Receives Notice of Delisting from American Stock Exchange; Company to Continue to Negotiate Potential Compliance-AAMEX:DORDor Biopharma
14/10/200515:17Business WireDOR BioPharma Provides Update on Programs and Corporate MattersAMEX:DORDor Biopharma
15/09/200523:41PR Newswire (US)Dr. Chris Dale, Vice President, Technology, Cambrex Biopharmaceuticals and Dr. Robert N. Brey, Chief Scientific Officer, DOR BioAMEX:DORDor Biopharma
26/07/200519:07PR Newswire (US)DOR BioPharma and Dowpharma Enter Into a Joint Development Agreement for BT-VACC(TM), DOR's Oral Vaccine Against Botulinum ToxinAMEX:DORDor Biopharma
15/06/200512:30Business WireDOR BioPharma, Inc. Announces Positive Interim Results from Phase I Clinical Trial of RiVax, Its Ricin Toxin VaccineAMEX:DORDor Biopharma
13/06/200517:14Business WireDOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Security and Connectivity ConferenceAMEX:DORDor Biopharma
04/05/200516:51Business WireDOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare ConferenceAMEX:DORDor Biopharma
04/05/200514:30Business WireDOR BioPharma Appoints T. Jerome Madison to Board of DirectorsAMEX:DORDor Biopharma
07/01/200514:30PR Newswire (US)DOR BioPharma and Cambrex Enter into a Development and Manufacturing Process Agreement for RiVax(TM)AMEX:DORDor Biopharma
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:DOR

La tua Cronologia

LATK
XDCEETH
XinFin XDCE
EU
BFCIF
BFCM Bfcm3.625%sep32nv
BIT
P1J7C3
BNP Paribas Issuance
TSXV
XGC
Xali Gold
TSXV
SUL
Sultan Minerals Inc.
COIN
COIBTC
Coinnec
LSE
AIGV
BIT
P1KV86
BNP Paribas Issuance
COIN
EVAAETH
Evanesco Network
EU
APHSQ
Paris Aphp3.538%20apr38
EU
BE0002936178
Crelan SA Bond 6000% unt...
EU
HMES
HSBC ETFs
LSE
TEK
Tekcapital
USOTC
EFGXY
EFG (PK)
USOTC
VWFB
VWF Bancorp (QX)
BIT
P1JNC1
BNP Paribas Issuance BV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network